Optiscan Imaging was recently highlighted in Stockhead’s article on ASX-listed companies leading innovation in diagnostics and procedures. The article emphasizes Optiscan’s cutting-edge imaging technology, stating: “Optiscan Imaging has developed a miniaturised confocal microscope, bringing high-resolution, real-time digital pathology to clinicians, reducing the need for traditional biopsies and improving patient outcomes.”

By transforming real-time diagnostics, Optiscan is playing a key role in advancing medical and surgical practices.

Read the full article here.